Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
The European Commission’s recently updated rolling plan confirms that the EU implementing act on the reprocessing of single-use medical devices, needed for the implementation of the Medical Device Regulation (MDR) is “undergoing formal adoption” and that the expected date of adoption is November 2019. The draft implementing act is out for comment until 20 August 2019.
The rolling plan also reveals that, in total, the European Commission has received 52 applications for designation as a notified body under the new MDR and IVDR and that 33 joint assessments of these applicants by the designating authorities have been carried out. New designations, Medtech Insight notes, are starting to roll out slowly.
As expected in our summary of the last update to the rolling plan in April, the commission adopted an implementing act – on 6 June 2019 – on the designation of issuing entities that will be responsible for the assignment of Unique Device Identification to medtech products.
Now on the agenda for adoption during the third and fourth quarters of this year are the following:
|
Target Dates |
Comments |
|
Third Quarter 2019 |
|
|
Standardization request to EU standards organization to align medtech standards to new regulations. |
Undergoing adoption procedure. Decision was expected by Q3 2019 although,Medtech Insightnotes, there are sometricky hurdles to be navigated around |
|
|
|
|
Fourth Quarter 2019 |
|
|
Eudamed implementing act on definition of detailed arrangements necessary to set up and support database |
In preparation |
|
Eudamed independent audit report on Eudamed achieving full functionality |
Audit is due to start in Q3/Q4 and be finalized by Q1 2020. |
|
Common specifications for IVD Class D |
These are needed in the context of the scrutiny mechanism for high-risk devices |
|
Rules to facilitate fulfillment of tasks under IVDR by EU reference laboratories |
Implementing act in preparation |
|
Expert panel fees |
Survey currently with members of European Commission group that helps with the implementation of the regulations, the Medical Device Coordination Group. |
Also recently made available by the European Commission is a FAQ document explaining the Unique Device Identification System, which includes a useful timetable for deadlines for pacing UDI carriers on medical devices and IVDs.
Medtech Insight: global medical technology news & analysis
By Brian Yang
The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, diagnostics companies are rushing to have test kits ready.
Topics Coronovirus
Medtech Insight: global medical technology news & analysis
By Marion Webb
An expert panel at CES 2020 discussed Deloitte's vision for health care in 2040, with the empowered consumer managing their own health, enabled by a new ecosystem of secure, open access to data and "nudges" to change behaviors. Consulting firm Deloitte foresees outside disruptors dismantling the traditional health-care system, but panelists from Johnson & Johnson and Anthem flexed their muscles.
Medtech Insight: global medical technology news & analysis
The US-Mexico-Canada (USMCA) treaty calls for the three countries to “recognize audits” performed under the Medical Device Single Audit Program. MDSAP is already used by device makers in the US and Canada so they can undergo one audit by an accredited third party to satisfy quality regulations. That leaves Mexico as the odd country out when it comes to using the popular program – and that means it has some catching up to do after the USMCA is ratified by all three nations. Former longtime FDA official Kim Trautman weighs in on how Mexico can incorporate MDSAP into its regulatory framework.
Request a Trial
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
Get a window into what the leading players across the biopharma, medtech, and diagnostics industries are thinking, as well as important insight into what your competitors are doing. Build your strategy with In Vivo.
In the continually evolving medtech competitive landscape, it is vital to stay up-to-date with key events. With Meddevicetracker, you’ll be able to anticipate upcoming filings, research clinical trial dates and data, and access market size information and expert forecasts, all in one place.
Looking for more products Product Finder
